Industry must not be allowed to block sharing of knowledge for medicines and vaccines
Within a year of the first reported covid-19 cases, effective vaccines were approved in Europe and North America using technology that would win the Nobel prize.12 Yet just 1% of all vaccines produced in the first year went to low income countries.3 Much the same happened in the early years of HIV treatment. Breakthrough antiretroviral therapy slashed mortality in high income countries, but drugs were priced out of reach for people in Africa, Asia, and Latin America until intellectual property and production barriers were overcome and generic versions arrived.4 In both cases, remarkable scientific victory was undermined by similarly remarkable equity failure. The pandemics were prolonged, took many more lives, and had highly unequal impacts because of inequitable distribution.567
In the wake of covid-19, governments are negotiating a treaty (accord) to create an international legal framework for sta
Building on previous declarations and other precedents, all three UN Member States should make bold commitments to protect vulnerable populations, embed equitable access terms on publicly funded research, collaborate on delinkage incentives models, and recognize the importance of community-led initiatives.
FEBRUARY 14 ― As embodied by the National Strategic Plan for Ending AIDS (2016-2030), the government has highlighted its intention to halt and reverse the AIDS epidemic by.
COVID-19 Collection thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
COVID-19 Collection thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.